Arques, France

Antoine Marcoz

This inventor holds 4 USPTO granted patents. Top assignee: Nemera La Verpilliere. Active years: 2024-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Antoine Marcoz. Retrieved from https://idiyas.com/inventor/antoine-marcoz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Antoine Marcoz: Innovator in Nasal Spray Technology

Introduction

Antoine Marcoz is a notable inventor based in Arques-la-Bataille, France. He has made significant contributions to the field of medical devices, particularly in the development of nasal spray technology. With a total of 4 patents to his name, Marcoz continues to push the boundaries of innovation in healthcare.

Latest Patents

One of Marcoz's latest inventions is a nasal spray device, which showcases his commitment to improving patient care through innovative solutions. This device is designed to enhance the delivery of medication, making it more effective and user-friendly.

Career Highlights

Marcoz is currently employed at Nemera La Verpilliere, a company known for its expertise in drug delivery systems. His work at Nemera has allowed him to collaborate with other talented professionals in the field, further advancing his career and contributions to medical technology.

Collaborations

Throughout his career, Marcoz has worked alongside talented colleagues such as Gaëtan Painchaud and Jérôme Genin. These collaborations have enriched his experience and fostered a creative environment for innovation.

Conclusion

Antoine Marcoz is a dedicated inventor whose work in nasal spray technology exemplifies the impact of innovation in healthcare. His contributions continue to shape the future of medical devices, improving the lives of patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…